(Q41419031)

30 September 2017

1 reference

title

Late relapse of germ cell tumors after cisplatin-based chemotherapy (English)

1 reference

30 September 2017

1 reference

A Gerl

1

1 reference

30 September 2017

C Clemm

2

1 reference

30 September 2017

N Schmeller

3

1 reference

30 September 2017

M Hentrich

4

1 reference

30 September 2017

R Lamerz

5

1 reference

30 September 2017

W Wilmanns

6

1 reference

30 September 2017

publication date

1 January 1997

1 reference

30 September 2017

1 reference

30 September 2017

volume

8

1 reference

30 September 2017

issue

1

1 reference

30 September 2017

page(s)

41-47

1 reference

Treatment of testicular cancer: a new and improved model

30 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008253323854

7 January 2021

Advances in the management of metastatic non-seminomatous germ cell tumours during the cisplatin era: a single-institution experience

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008253323854

7 January 2021

Late relapse of testicular cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008253323854

7 January 2021

Late recurrences in long-term survivors of germ cell neoplasms

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008253323854

7 January 2021

Late relapse of testicular cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008253323854

7 January 2021

Cis-Diamminedichloroplatinum, Vinblastine, and Bleomycin Combination Chemotherapy in Disseminated Testicular Cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008253323854

7 January 2021

Etoposide, Cisplatin, Bleomycin, And Cyclophosphamide (Ecbc) As First-Line Chemotherapy for Poor-Risk Non-Seminomatous Germ Cell Tumors

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008253323854

7 January 2021

Treatment of disseminated germ-cell tumors with cisplatin, bleomycin, and either vinblastine or etoposide

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008253323854

7 January 2021

Sequential resection of residual abdominal and thoracic masses after chemotherapy for metastatic non-seminomatous germ cell tumours

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008253323854

7 January 2021

Outcome analysis after post-chemotherapy surgery in patients with non-seminomatous germ cell tumours

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008253323854

7 January 2021

Vinblastine-ifosfamide-cisplatin treatment of bulky seminoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008253323854

7 January 2021

Advanced seminoma: treatment results, survival, and prognostic factors in 142 patients

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008253323854

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008253323854

7 January 2021

The Second Medical Research Council study of prognostic factors in nonseminomatous germ cell tumors. Medical Research Council Testicular Tumour Working Party

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008253323854

7 January 2021

Late recurrence of mature teratoma in nonseminomatous testicular tumors after PVB chemotherapy and surgery

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008253323854

7 January 2021

Prognosis after salvage treatment for unselected male patients with germ cell tumours

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008253323854

7 January 2021

Late recurrence of testicular cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008253323854

7 January 2021

Cisplatinum Dose Dependent Response in Germ Cell Cancer Evaluated by Tumour Marker Modelling

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008253323854

7 January 2021

Testicular tumor after cisplatin-based chemotherapy for germ cell malignancy

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008253323854

7 January 2021

False elevations of alpha-fetoprotein associated with liver dysfunction in germ cell tumors

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008253323854

7 January 2021

Cost and risk benefit in the management of clinical stage II nonseminomatous testicular tumors.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008253323854

7 January 2021

Primary chemotherapy for stage II nonseminomatous germ cell tumors of the testis

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008253323854

7 January 2021

Identifiers

DOI

10.1023/A:1008253323854

1 reference

30 September 2017

1 reference